China Pharma Holdings Inc. Revenue 2010–2025
China Pharma Holdings Inc. annual/quarterly revenue history and growth rate from 2010 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- China Pharma Holdings Inc. revenue for the quarter ending March 31, 2026 was 983536, a 13.44% decrease year-over-year.
- China Pharma Holdings Inc. revenue for the twelve months ending March 31, 2026 was 3.9 M, a 24.94% decrease year-over-year.
- China Pharma Holdings Inc. annual revenue for 2025 was 4.1 M, a 8.49% decrease from 2024.
- China Pharma Holdings Inc. annual revenue for 2024 was 4.5 M, a 35.41% decrease from 2023.
- China Pharma Holdings Inc. annual revenue for 2023 was 7.0 M, a 13.48% decrease from 2022.
- China Pharma Holdings Inc. annual revenue for 2022 was 8.1 M.
China Pharma Holdings Inc. (CPHI) — Frequently Asked Questions
China Pharma Holdings Inc. (CPHI) is a publicly traded US company. It has a market capitalization of $12M. In fiscal 2025 it reported revenue of $4M and net income of -$3M. Explore CPHI's stock price, financial statements, earnings history, margins and key ratios below.
What is China Pharma Holdings Inc.'s market cap?
China Pharma Holdings Inc. (CPHI) has a market capitalization of $12M.
What is the CPHI stock price?
CPHI trades at $0.77 (+7.33% on the day).
How much revenue does China Pharma Holdings Inc. make?
China Pharma Holdings Inc. reported revenue of $4M in fiscal 2025.
Is CPHI profitable?
In fiscal 2025, China Pharma Holdings Inc. reported net income of -$3M.